Results: after 15 days of treatment, VAS score of the experimental group decreased significally from 5.73±0.73 to 1.3±0.47 (p<0.05), no statistically significant heterogeneity between two groups (VAS score of control group decreased from 6.0 ± 0.44 to 1.63±0.61) (p>0.05); 60% patients of experimental group improved daily activities, it seems the same with control group (53.3%) (p>0.05).